Book Chapters

To date I have written 17 book chapters, mostly on the topics of cholesterol and lipid metabolism and the clinical pharmacology of lipid regulating drugs.

References for the book chapters are listed below (please select the year from the drop down box) or you can download the full list as a pdf file.

2004

  1. Gaw, A. , Packard, C.J. & Shepherd J. Lipid and lipid-modifying therapy. Chapter 3 In: Atherosclerosis and Heart Disease (Ed. A. Tonkin) Martin Dunitz, London, 2004.
  2. Mungall, M.M.B. and Gaw, A. Lipids and lipid-modifying therapy. Chapter 7 In: Men's Health 2nd Edn, (Eds. Kirby RS, Carsson CC, Kirby MG & Farah RN, Martin Dunitz) London, 2004.
  3. Gaw, A. Lipids and lipid lowering drugs. Chapter 3 in: Coronary heart Disease Prevention: A Handbook for the Healthcare Team 2nd Edn, (Eds. Lindsay, G.M. and Gaw, A.) Churchill Livingstone, Edinburgh, 2004.

2003

  1. Packard, C.J., Gaw, A., and Shepherd, J. Cholesterol-lowering agents and their use, version 1.0. In: Encyclopedia of Life Sciences. London: Nature Publishing Group. [doi: 10.1038/npg.els.0002265]http://www.els.net/2003.

1999

  1. Gaw, A. & Shepherd J. The West of Scotland Coronary Prevention Study. Chapter 4 In: Cholesterol Lowering Therapies (Ed S.M. Grundy) Marcel Dekker Inc, New York 1999.
  2. Gaw, A. and Shepherd J.: Fibric Acid Derivatives. Chapter 65 pp 1145-1160 In: Lipoproteins in Health and Disease. (Eds. Betteridge, D.J., Illingworth, D.R., and Shepherd, J.) Edward Arnold, London, 1999.
  3. Gaw, A. and Hobbs, H.H.: Lipoprotein (a). Chapter 6 pp 87-109 In: Lipoproteins in Health and Disease. (Eds. Betteridge, D.J., Illingworth, D.R., and Shepherd, J.) Edward Arnold, London, 1999.
  4. Gaw, A. and Packard, C.J.: Investigation of lipoprotein metabolism. Chapter 27 pp 491-521 In: Lipoproteins in Health and Disease. (Eds. Betteridge, D.J., Illingworth, D.R., and Shepherd, J.) Edward Arnold, London, 1999.
  5. Shepherd, J and Gaw, A: Fenofibrate. Chapter 117 pp 1083-1092 In: Cardiovascular Drug Therapy 2nd Edn (Ed. Messerli, F.H.) . B. Saunders Company, Philadelphia, 1999.

1998

  1. Gaw, A. and Shepherd, J. Management of Dyslipidaemias in Diabetes. In: Diabetes Annual 11th Volume. (Eds Marshall, S.M., Home, P.D. and Rizza, R.) 1998.

1997

  1. Gaw, A., Lindsay, G.M., and Shepherd, J.: Atherosclerosis. Chapter 8 In: Mechanisms of Disease. (Eds. Tomlinson, S., Hegarty, A.M.,and Weetman, A.P.) Cambridge University Press, Cambridge, 1997.
  2. Gaw, A. Lipid lowering drug therapy. Chapter 10 in: Lindsay, G.M. and Gaw, A. (eds) Coronary heart Disease Prevention: A Handbook for the Healthcare Team, Churchill Livingstone, Edinburgh, 1997.
  3. Gaw, A. and Shepherd, J. Cholesterol and lipoproteins. Chapter 3 in: Lindsay, G.M. and Gaw, A. (eds) Coronary heart Disease Prevention: A Handbook for the Healthcare Team, Churchill Livingstone, Edinburgh, 1997.

1994

  1. Gaw, A., Packard, C.J., and Shepherd, J.: Fibrates. Chapter 12 (p325-348) In: Handbook of Experimental Pharmacology Vol: 109 Principles and Treatment of Lipoprotein Disorders (Eds. Schettler, G., Habenicht, A.J.R.) Springer-Verlag, Munich, 1994.
  2. Gaw, A., Packard, C.J., and Shepherd, J.: Lipids and atherosclerosis. Chapter 50 (p1153-1168) In: Haemostasis and Thrombosis 3rd Ed. (Eds Bloom, A.L., Forbes C.D., Thomas, D.P., and Tuddenham E.G.D.) Churchill Livingstone, Edinburgh, 1994.

1992

  1. Gaw, A., Packard, C.J., and Shepherd, J.: Lipoprotein turnover and metabolism. Chapter 5 (p119-144) In: Lipoprotein Analysis. A Practical Approach. (Ed Converse, C.A. and Skinner, E.R.). IRL Press at Oxford University Press. 1992.
  2. Gaw, A., Stewart, J.P., Pappu, A.S., Illingworth, D.R., Vallance, B.D., Packard, C.J., and Shepherd, J.: Urinary mevalonic acid and plasma lathosterol: Responses to fenofibrate therapy. Chapter 130 In: Molecular Biology of Atherosclerosis (Ed. M.J. Halpern), John Libbey and Co., Ltd., London, 1992.